ITRM Financial Statements

Balance sheet, income statement, cash flow, and dividends for Iterum Therapeutics Plc (ITRM).


$48.70M Market Cap.

As of 02/07/2025 5:00 PM ET (MRY) • Disclaimer

ITRM Market Cap. (MRY)


ITRM Shares Outstanding (MRY)


ITRM Assets (MRY)


Total Assets

$44.59M

Total Liabilities

$48.68M

Total Investments

$0

ITRM Income (MRY)


Revenue

$0

Net Income

-$24.77M

Operating Expense

$18.44M

ITRM Cash Flow (MRY)


CF Operations

-$26.77M

CF Investing

$18.21M

CF Financing

$26.69M

ITRM Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

ITRM Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$44,595,000 (69.83%)

$26,259,000 (-60.71%)

$66,833,000 (-26.97%)

$91,509,000 (179.06%)

Assets Current

$24,787,000 (-3.16%)

$25,596,000 (-59.01%)

$62,444,000 (-25.01%)

$83,266,000 (287.79%)

Assets Non-Current

$19,808,000 (2887.63%)

$663,000 (-84.89%)

$4,389,000 (-46.75%)

$8,243,000 (-27.18%)

Goodwill & Intangible Assets

$19,746,000 (0%)

$0 (0%)

$1,719,000 (-49.96%)

$3,435,000 (0%)

Shareholders Equity

-$4,081,000 (36.26%)

-$6,403,000 (-122.87%)

$27,999,000 (-44.26%)

$50,234,000 (199.36%)

Property Plant & Equipment Net

$23,000 (-54.90%)

$51,000 (-26.09%)

$69,000 (-24.18%)

$91,000 (-78.38%)

Cash & Equivalents

$24,159,000 (295.72%)

$6,105,000 (-71.10%)

$21,126,000 (-23.21%)

$27,510,000 (88.84%)

Accumulated Other Comprehensive Income

$0 (0%)

$1,000 (100.29%)

-$350,000 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$17,859,000 (-55.03%)

$39,712,000 (-26.32%)

$53,898,000 (21633.06%)

Investments Current

$0 (0%)

$17,859,000 (-55.03%)

$39,712,000 (-26.32%)

$53,898,000 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$251,000 (-94.98%)

$4,996,000 (80.10%)

$2,774,000 (215.95%)

$878,000 (7.60%)

Accumulated Retained Earnings (Deficit)

-$486,072,000 (-5.37%)

-$461,298,000 (-9.07%)

-$422,927,000 (-11.74%)

-$378,493,000 (-31.91%)

Tax Assets

$48,000 (26.32%)

$38,000 (-87.42%)

$302,000 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$221,000 (116.67%)

Total Debt

$45,534,000 (140.21%)

$18,956,000 (-33.41%)

$28,466,000 (7.32%)

$26,525,000 (-37.35%)

Debt Current

$14,463,000 (0%)

$0 (0%)

$0 (0%)

$1,627,000 (-74.92%)

Debt Non-Current

$31,071,000 (63.91%)

$18,956,000 (-33.41%)

$28,466,000 (14.33%)

$24,898,000 (-30.55%)

Total Liabilities

$48,676,000 (49.03%)

$32,662,000 (-15.89%)

$38,834,000 (-5.91%)

$41,275,000 (-50.48%)

Liabilities Current

$17,605,000 (30.23%)

$13,518,000 (49.14%)

$9,064,000 (-29.96%)

$12,941,000 (-68.96%)

Liabilities Non-Current

$31,071,000 (62.30%)

$19,144,000 (-35.69%)

$29,770,000 (5.07%)

$28,334,000 (-31.98%)

ITRM Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$254,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$7,984,000 (6.80%)

$7,476,000 (-41.44%)

$12,766,000 (-7.66%)

$13,825,000 (25.09%)

Research & Development Expense

$10,458,000 (-73.85%)

$39,992,000 (127.01%)

$17,617,000 (64.46%)

$10,712,000 (-49.17%)

Operating Expenses

$18,442,000 (-61.15%)

$47,468,000 (56.23%)

$30,383,000 (23.83%)

$24,537,000 (-23.62%)

Interest Expense

$2,522,000 (76.61%)

$1,428,000 (-39.52%)

$2,361,000 (-57.48%)

$5,553,000 (-63.22%)

Income Tax Expense

$240,000 (-60.85%)

$613,000 (103.65%)

$301,000 (-57.30%)

$705,000 (-5.11%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$24,774,000 (35.44%)

-$38,371,000 (13.64%)

-$44,434,000 (51.47%)

-$91,564,000 (-76.06%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$24,774,000 (35.44%)

-$38,371,000 (13.64%)

-$44,434,000 (51.47%)

-$91,564,000 (-76.06%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$24,774,000 (35.44%)

-$38,371,000 (13.64%)

-$44,434,000 (51.47%)

-$91,564,000 (-76.06%)

Weighted Average Shares

$19,699,260 (51.97%)

$12,962,362 (5.93%)

$12,236,607 (12.35%)

$10,891,178 (580.42%)

Weighted Average Shares Diluted

$19,699,260 (51.97%)

$12,962,362 (5.93%)

$12,236,607 (12.35%)

$10,891,178 (580.42%)

Earning Before Interest & Taxes (EBIT)

-$22,012,000 (39.41%)

-$36,330,000 (13.03%)

-$41,772,000 (51.03%)

-$85,306,000 (-135.87%)

Gross Profit

-$254,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$18,696,000 (60.61%)

-$47,468,000 (-56.23%)

-$30,383,000 (-23.83%)

-$24,537,000 (23.62%)

ITRM Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$18,208,000 (-21.97%)

$23,336,000 (67.20%)

$13,957,000 (125.56%)

-$54,595,000 (-496218.18%)

Net Cash Flow from Financing

$26,691,000 (2481.33%)

$1,034,000 (156.88%)

-$1,818,000 (-102.19%)

$83,127,000 (28.93%)

Net Cash Flow from Operations

-$26,770,000 (31.93%)

-$39,330,000 (-112.91%)

-$18,473,000 (-16.61%)

-$15,842,000 (70.95%)

Net Cash Flow / Change in Cash & Cash Equivalents

$18,054,000 (220.19%)

-$15,021,000 (-135.29%)

-$6,384,000 (-150.29%)

$12,694,000 (27.90%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$18,210,000 (-22.01%)

$23,349,000 (66.55%)

$14,019,000 (125.71%)

-$54,534,000 (0%)

Capital Expenditure

-$2,000 (84.62%)

-$13,000 (79.03%)

-$62,000 (-1.64%)

-$61,000 (-454.55%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

-$2,251,000 (65.45%)

-$6,516,000 (-18.71%)

Issuance (Purchase) of Equity Shares

$26,691,000 (2481.33%)

$1,034,000 (138.80%)

$433,000 (-99.52%)

$89,643,000 (28.13%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

-$75,000 (-22.95%)

-$61,000 (-22.00%)

-$50,000 (-1350.00%)

$4,000 (136.36%)

Share Based Compensation

$363,000 (-53.70%)

$784,000 (-83.52%)

$4,758,000 (10.16%)

$4,319,000 (56.54%)

Depreciation Amortization & Accretion

$284,000 (-83.77%)

$1,750,000 (-2.78%)

$1,800,000 (-14.45%)

$2,104,000 (1206.83%)

ITRM Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

303.50% (145.71%)

-664.00% (-471.92%)

-116.10% (42.50%)

-201.90% (-291.19%)

Return on Average Assets (ROAA)

-105.10% (-19.98%)

-87.60% (-47.47%)

-59.40% (33.33%)

-89.10% (42.99%)

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

-139.80% (-76.07%)

-79.40% (-31.89%)

-60.20% (55.27%)

-134.60% (43.13%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-1.41 (-110.96%)

-0.67 (-188.31%)

-0.23 (66.95%)

-0.7 (-52.95%)

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

-11.93 (-197.24%)

-4.01 (-1194.01%)

0.37 (-74.26%)

1.43 (269.36%)

Debt to Equity Ratio (D/E)

-11.93 (-133.82%)

-5.1 (-467.77%)

1.39 (68.73%)

0.82 (149.85%)

Earnings Per Share (EPS)

-1.26 (57.43%)

-2.96 (18.46%)

-3.63 (56.84%)

-8.41 (74.12%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-1.36 (55.22%)

-3.04 (-100.33%)

-1.51 (-3.77%)

-1.46 (95.72%)

Book Value Per Share (BVPS)

-0.21 (58.10%)

-0.49 (-121.59%)

2.29 (-50.39%)

4.61 (114.60%)

Tangible Assets Book Value Per Share (TABVPS)

1.26 (-37.76%)

2.03 (-61.92%)

5.32 (-34.20%)

8.09 (-60.53%)

Enterprise Value Over EBIT (EV/EBIT)

-3 (-200.00%)

-1 (0%)

0 (0%)

-1 (50.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

-2.66 (-127.01%)

-1.17 (-134.00%)

-0.5 (34.38%)

-0.76 (63.05%)

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

1.41 (-25.62%)

1.89 (-72.52%)

6.89 (7.07%)

6.43 (1149.32%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$26,772,000 (31.95%)

-$39,343,000 (-112.26%)

-$18,535,000 (-16.55%)

-$15,903,000 (70.84%)

Enterprise Value (EV)

$57,699,189 (42.64%)

$40,451,514 (102.54%)

$19,972,034 (-68.50%)

$63,410,355 (-14.58%)

Earnings Before Tax (EBT)

-$24,534,000 (35.02%)

-$37,758,000 (14.44%)

-$44,133,000 (51.43%)

-$90,859,000 (-77.24%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$21,728,000 (37.17%)

-$34,580,000 (13.49%)

-$39,972,000 (51.96%)

-$83,202,000 (-131.08%)

Invested Capital

$28,619,000 (11.83%)

$25,592,000 (-59.63%)

$63,390,000 (-14.51%)

$74,148,000 (293.05%)

Working Capital

$7,182,000 (-40.54%)

$12,078,000 (-77.37%)

$53,380,000 (-24.10%)

$70,325,000 (447.70%)

Tangible Asset Value

$24,849,000 (-5.37%)

$26,259,000 (-59.67%)

$65,114,000 (-26.07%)

$88,074,000 (168.58%)

Market Capitalization

$48,703,189 (89.44%)

$25,708,514 (150.18%)

$10,276,034 (-85.65%)

$71,611,355 (68.25%)

Average Equity

-$8,162,750 (-241.25%)

$5,778,750 (-84.90%)

$38,267,250 (-15.62%)

$45,348,500 (192.08%)

Average Assets

$23,579,500 (-46.14%)

$43,782,000 (-41.46%)

$74,784,500 (-27.24%)

$102,785,250 (208.99%)

Invested Capital Average

$15,743,250 (-65.59%)

$45,754,500 (-34.09%)

$69,415,000 (9.53%)

$63,373,000 (314.83%)

Shares

27,515,926 (110.85%)

13,050,007 (6.68%)

12,233,374 (0.40%)

12,185,025 (324.71%)